- Home
- DNTH vs NFE Comparison
DNTH vs NFE Comparison
Compare DNTH & NFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- NFE
- Stock Information
- Founded
- DNTH 2015
- NFE 2014
- Country
- DNTH United States
- NFE United States
- Employees
- DNTH N/A
- NFE N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- NFE Oil/Gas Transmission
- Sector
- DNTH Health Care
- NFE Utilities
- Exchange
- DNTH Nasdaq
- NFE Nasdaq
- Market Cap
- DNTH 780.2M
- NFE 773.2M
- IPO Year
- DNTH N/A
- NFE 2019
- Fundamental
- Price
- DNTH $26.50
- NFE $2.45
- Analyst Decision
- DNTH Strong Buy
- NFE Strong Buy
- Analyst Count
- DNTH 8
- NFE 6
- Target Price
- DNTH $54.00
- NFE $8.92
- AVG Volume (30 Days)
- DNTH 374.5K
- NFE 6.5M
- Earning Date
- DNTH 11-06-2025
- NFE 11-06-2025
- Dividend Yield
- DNTH N/A
- NFE N/A
- EPS Growth
- DNTH N/A
- NFE N/A
- EPS
- DNTH N/A
- NFE N/A
- Revenue
- DNTH $4,854,000.00
- NFE $2,006,240,000.00
- Revenue This Year
- DNTH N/A
- NFE $7.43
- Revenue Next Year
- DNTH N/A
- NFE $8.38
- P/E Ratio
- DNTH N/A
- NFE N/A
- Revenue Growth
- DNTH 17.87
- NFE N/A
- 52 Week Low
- DNTH $13.37
- NFE $2.01
- 52 Week High
- DNTH $32.27
- NFE $16.66
- Technical
- Relative Strength Index (RSI)
- DNTH 70.68
- NFE 43.46
- Support Level
- DNTH $22.81
- NFE $2.23
- Resistance Level
- DNTH $24.81
- NFE $2.76
- Average True Range (ATR)
- DNTH 1.57
- NFE 0.20
- MACD
- DNTH 0.22
- NFE 0.03
- Stochastic Oscillator
- DNTH 91.57
- NFE 40.91
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About NFE New Fortress Energy Inc.
New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.